1. Home
  2. PRPO vs MYO Comparison

PRPO vs MYO Comparison

Compare PRPO & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precipio Inc.

PRPO

Precipio Inc.

HOLD

Current Price

$23.34

Market Cap

40.1M

Sector

Industrials

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.24

Market Cap

33.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPO
MYO
Founded
N/A
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.1M
33.3M
IPO Year
2000
2017

Fundamental Metrics

Financial Performance
Metric
PRPO
MYO
Price
$23.34
$1.24
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
18.4K
1.2M
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
92.15
N/A
EPS
N/A
N/A
Revenue
$24,049,000.00
$1,000,000,000.00
Revenue This Year
N/A
$9.10
Revenue Next Year
N/A
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
29.77
40814.79
52 Week Low
$10.60
$0.61
52 Week High
$33.63
$2.38

Technical Indicators

Market Signals
Indicator
PRPO
MYO
Relative Strength Index (RSI) 46.27 53.11
Support Level $21.71 $0.76
Resistance Level $24.30 N/A
Average True Range (ATR) 1.11 0.18
MACD 0.26 -0.03
Stochastic Oscillator 66.88 23.33

Price Performance

Historical Comparison
PRPO
MYO

About PRPO Precipio Inc.

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: